Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
Titel:
Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
Auteur:
Metzger Filho, O. Leone, J.P. Li, T. Tan-Wasielewski, Z. Trippa, L. Barry, W.T. Younger, J. Lawler, E. Walker, L. Freedman, R.A. Tolaney, S.M. Krop, I. Winer, E.P. Lin, N.U.